Reminder: Invitation to Roche's Pharma Day 2023 Donnerstag, 31. August 2023 - 10:51

The Roche Investor Relations team would like to invite you to the Roche Pharma Day that will take place in London on Monday, 11 September 2023, starting at 10:00 BST and finishing at 14:30 BST with a reception.

The Roche Pharma Day will address the following topics:

• Group / Pharma strategy
• Commercial growth drivers
• Pipeline updates
  • Oncology, Hematology, Neuroscience, Ophthalmology, Immunology

Presenters include:

• Thomas Schinecker, CEO Roche Group
• Teresa Graham, CEO Roche Pharmaceuticals
• Levi Garraway, Chief Medical Officer and Head of Global Product Development
• Charlie Fuchs, Senior Vice President and Global Head of Oncology and Hematology
• Paulo Fontoura, Senior Vice President and Global Head of Neuroscience, Immunology, Ophthalmology, Infectious and Rare Diseases Clinical Development
• Christopher Brittain, Vice President and Global Head Product Development Ophthalmology

You will have the opportunity to meet senior management during the event.

Meeting information: 

Date/Time (BST):

Monday, 11 September 2023
10:00 Registration
10:30 Event starts
14:30 Event ends, followed by refreshments with Roche Management Team

Venue
etc.venues St Paul's
200 Aldersgate
London EC1A 4HD
map

To register for the event, please follow this > link (passcode: Pharma2023)

The slides will be available for download at 9:30 BST on the day of the event.
> click here

For participants who join via the webinar, the event will be listen-only apart from the Q&A where written questions can be submitted via a chat function. Pre-registration is required, please register for the webinar here*.

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com .

A replay of the event will be available via > ir.roche.com

*privacy notice

Best regards,

Bruno Eschli
Head of Investor Relations

Loren Kalm
Head of Investor Relations North America

Roche Investor Relations

Dr. Bruno Eschli

Phone: +41 61 68-75284

e-mail: bruno.eschli@roche.com

Dr. Sabine Borngräber

Phone: +41 61 68-88027

e-mail: sabine.borngraeber@roche.com

Dr. Birgit Masjost

Phone: +41 61 68-84814

e-mail: birgit.masjost@roche.com

Dr. Gerard Tobin

Phone: +41 61 68-72942

e-mail: gerard.tobin@roche.com

Investor Relations North America

Loren Kalm

Phone: +1 650 225 3217

e-mail: kalm.loren@gene.com